Author:
Karcini Arba,Lazar Iulia M.
Abstract
AbstractThe plasma membrane proteome resides at the interface between the extra- and intra-cellular environment and through its various roles in signal transduction, immune recognition, nutrient transport, and cell–cell/cell–matrix interactions plays an absolutely critical role in determining the fate of a cell. Our work was aimed at exploring the cell-membrane proteome of a HER2+ breast-cancer cell line (SKBR3) to identify triggers responsible for uncontrolled cell proliferation and intrinsic resources that enable detection and therapeutic interventions. To mimic environmental conditions that enable cancer cells to evolve adaptation/survival traits, cell culture was performed under serum-rich and serum-deprived conditions. Proteomic analysis enabled the identification of ~ 2000 cell-membrane proteins. Classification into proteins with receptor/enzymatic activity, CD antigens, transporters, and cell adhesion/junction proteins uncovered overlapping roles in processes that drive cell growth, apoptosis, differentiation, immune response, adhesion and migration, as well as alternate pathways for proliferation. The large number of tumor markers (> 50) and putative drug targets (> 100) exposed a vast potential for yet unexplored detection and targeting opportunities, whereas the presence of 15 antigen immunological markers enabled an assessment of epithelial, mesenchymal or stemness characteristics. Serum-starved cells displayed altered processes related to mitochondrial OXPHOS/ATP synthesis, protein folding and localization, while serum-treated cells exhibited attributes that support tissue invasion and metastasis. Altogether, our findings advance the understanding of the biological triggers that sustain aberrant cancer cell proliferation, survival and development of resistance to therapeutic drugs, and reveal vast innate opportunities for guiding immunological profiling and precision medicine applications aimed at target selection or drug discovery.
Funder
National Institute of General Medical Sciences
Publisher
Springer Science and Business Media LLC
Reference85 articles.
1. Watkins, E. J. Overview of breast cancer. J. Am. Acad. PAs 32, 13–17 (2019).
2. Nahta, R. Novel therapies to overcome HER2 therapy resistance in breast cancer. In Current Applications for Overcoming Resistance to Targeted Therapies (ed. Szewczuk, M.R, Qorri, B., Sambi, M.) 191–221 (Springer, 2019).
3. Cooper, G. M. The Cell: A Molecular Approach 2nd edn. (Sinauer Associates, 2000).
4. Paul, A. I. et al. GPCRomics: GPCR expression in cancer cells and tumors identifies new, potential biomarkers and therapeutic targets. Front. Pharmacol. 9, 1–11 (2018).
5. Mark, A. L. & Joseph, S. Cell signaling by receptor tyrosine kinases. Cell 141, 1117–1134 (2010).
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献